| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |